company background image
GEMA logo

International Medical Center of Biomaterials Processing and Cryostorage MISX:GEMA Stock Report

Last Price

₽672.00

Market Cap

₽1.0b

7D

0%

1Y

-27.0%

Updated

05 Oct, 2022

Data

Company Financials

International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company

MISX:GEMA Stock Report

Market Cap: ₽1.0b

GEMA Stock Overview

International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company operates as a licensed bank for personal storage of cord blood stem cells and tissue of the umbilical cord in Russia and the CIS countries.

GEMA fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance5/6
Financial Health3/6
Dividends2/6

International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company Competitors

Price History & Performance

Summary of all time highs, changes and price drops for International Medical Center of Biomaterials Processing and Cryostorage
Historical stock prices
Current Share Price₽672.00
52 Week High₽1,250.00
52 Week Low₽601.00
Beta0.41
1 Month Change0%
3 Month Change-0.22%
1 Year Change-26.96%
3 Year Change4.84%
5 Year Changen/a
Change since IPO-2.40%

Recent News & Updates

Is International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company's (MCX:GEMA) Latest Stock Performance A Reflection Of Its Financial Health?

Jan 13
Is International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company's (MCX:GEMA) Latest Stock Performance A Reflection Of Its Financial Health?

Recent updates

Is International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company's (MCX:GEMA) Latest Stock Performance A Reflection Of Its Financial Health?

Jan 13
Is International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company's (MCX:GEMA) Latest Stock Performance A Reflection Of Its Financial Health?

Shareholder Returns

GEMARU HealthcareRU Market
7D0%-3.7%0.6%
1Y-27.0%-1.0%11.2%

Return vs Industry: GEMA underperformed the Russian Healthcare industry which returned 3.8% over the past year.

Return vs Market: GEMA exceeded the Russian Market which returned -38.2% over the past year.

Price Volatility

Is GEMA's price volatile compared to industry and market?
GEMA volatility
GEMA Average Weekly Movementn/a
Healthcare Industry Average Movement4.5%
Market Average Movement4.5%
10% most volatile stocks in RU Market10.0%
10% least volatile stocks in RU Market2.4%

Stable Share Price: GEMA has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine GEMA's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
2003n/an/ahttps://www.gemabank.ru

International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company operates as a licensed bank for personal storage of cord blood stem cells and tissue of the umbilical cord in Russia and the CIS countries. The company was founded in 2003 and is based in Moscow, Russia. International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company is a subsidiary of Human Stem Cells Institute PJSC.

International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company Fundamentals Summary

How do International Medical Center of Biomaterials Processing and Cryostorage's earnings and revenue compare to its market cap?
GEMA fundamental statistics
Market cap₽1.00b
Earnings (TTM)₽127.10m
Revenue (TTM)₽261.17m

7.9x

P/E Ratio

3.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
GEMA income statement (TTM)
Revenue₽261.17m
Cost of Revenue₽37.64m
Gross Profit₽223.53m
Other Expenses₽96.43m
Earnings₽127.10m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)85.13
Gross Margin85.59%
Net Profit Margin48.66%
Debt/Equity Ratio12.9%

How did GEMA perform over the long term?

See historical performance and comparison

Dividends

12.9%

Current Dividend Yield

111%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.